ICARES Medicus, Inc. (TPEX:6612)
73.30
-0.10 (-0.14%)
Aug 19, 2026, 1:30 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 347.66M TWD in the quarter ending June 30, 2026, with 29.15% growth. This brings the company's revenue in the last twelve months to 1.21B, up 12.00% year-over-year. In the year 2025, ICARES Medicus had annual revenue of 1.13B with 31.54% growth.
Revenue (ttm)
1.21B
Revenue Growth
+12.00%
P/S Ratio
2.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | 271.19M | 31.54% |
| Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
| Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
| Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
| Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.44B |
| Formosa Optical Technology | 4.39B |
| St.Shine Optical | 3.73B |
| Pacific Hospital Supply | 2.42B |
| Nang Kuang Pharmaceutical | 2.11B |
| Bionime | 1.72B |
| Chi Sheng Pharma & Biotech | 1.42B |
| SciVision Biotech | 889.15M |